rs35689081
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000409709.9(MYO7A):c.93C>A(p.Cys31Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000286 in 1,610,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C31C) has been classified as Likely benign.
Frequency
Consequence
ENST00000409709.9 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.93C>A | p.Cys31Ter | stop_gained | 3/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.93C>A | p.Cys31Ter | stop_gained | 3/49 | 1 | NM_000260.4 | ENSP00000386331 | ||
MYO7A | ENST00000458637.6 | c.93C>A | p.Cys31Ter | stop_gained | 3/49 | 1 | ENSP00000392185 | P1 | ||
MYO7A | ENST00000409619.6 | c.60C>A | p.Cys20Ter | stop_gained | 4/50 | 1 | ENSP00000386635 | |||
MYO7A | ENST00000660626.1 | c.183C>A | p.Cys61Ter | stop_gained | 2/2 | ENSP00000499401 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000372 AC: 9AN: 242144Hom.: 0 AF XY: 0.0000456 AC XY: 6AN XY: 131458
GnomAD4 exome AF: 0.0000302 AC: 44AN: 1458584Hom.: 0 Cov.: 33 AF XY: 0.0000359 AC XY: 26AN XY: 725088
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
Usher syndrome type 1B Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1999 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change creates a premature translational stop signal (p.Cys31*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is present in population databases (rs35689081, gnomAD 0.008%). This premature translational stop signal has been observed in individuals with Usher syndrome (PMID: 8900236, 10094549, 19074810, 27957503). It is commonly reported in individuals of Danish ancestry (PMID: 27957503). ClinVar contains an entry for this variant (Variation ID: 11859). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 19, 2023 | Observed in the heterozygous state in an individual with Usher syndrome in published literature (Weston et al., 1996; Janecke et al., 1999; Jacobson et al., 2009); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27957503, 25525159, 10094549, 20544672, 12112664, 28731162, 24199935, 8900236, 19074810, 25333064, 23770805, 30303587, 31266775, 34948090, 30718709) - |
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 22, 2017 | - - |
Hearing loss, autosomal recessive Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | - | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 03, 2017 | The p.Cys31X variant in MYO7A has been reported in at least 9 individuals with U sher syndrome type I, many of whom were either homozygous for this variant or co mpound heterozygous with a second pathogenic variant (Weston 1996, Janecke 1999, Jacobson 2008, Tranebj?rg 2011). It has been identified in 10/123920 European c hromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstit ute.org/; dbSNP rs35689081); this frequency in the general population is consist ent with a carrier frequency for autosomal recessive Usher syndrome. This nonsen se variant leads to a premature stop codon at position 31, which is predicted to lead to a truncated or absent protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome based upon its predicted impact and biallelic presence in previously reported affected ind ividuals. - |
Retinitis pigmentosa Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | Apr 01, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at